Novo Nordisk, Wegovy
Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...
The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...
List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback